13-Feb-2026
Healthpeak's Strategic Moves Signal Focus on Senior Housing and Life Science Real Estate
Market Chameleon (Tue, 3-Feb 3:52 AM ET)
Healthpeak Properties Provides Strategic Initiatives Update and Reports Fourth Quarter 2025 Results
Business Wire (Mon, 2-Feb 4:15 PM ET)
Healthpeak Advances AI-Enabled Operating Platform, Naming Omkar Joshi Head of Enterprise Innovation
Business Wire (Wed, 21-Jan 4:15 PM ET)
Healthpeak Properties Announces Tax Treatment of 2025 Distributions
Business Wire (Thu, 15-Jan 4:15 PM ET)
Healthpeak Properties Announces $925 Million of Transaction Activity
Business Wire (Mon, 12-Jan 6:59 AM ET)
Business Wire (Fri, 9-Jan 4:15 PM ET)
Business Wire (Wed, 7-Jan 7:01 AM ET)
Business Wire (Wed, 7-Jan 7:00 AM ET)
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the First Quarter of 2026
Business Wire (Mon, 5-Jan 4:15 PM ET)
KBW Announces Index Rebalancing for Fourth-Quarter 2025
Globe Newswire (Fri, 12-Dec 8:30 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of February 13, 2026, DOC stock price climbed to $16.70 with 8,552,211 million shares trading.
DOC has a beta of 0.42, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.09 to the broad based SPY ETF.
DOC has a market cap of $11.61 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $719 million in Revenue and $.47 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.25.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has underperformed the market in the last year with a price return of -7.8% while the SPY ETF gained +13.0%. DOC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.7% and -2.5%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
DOC support price is $15.86 and resistance is $16.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.